Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children()

BACKGROUND: Human parainfluenza virus type 3 (HPIV3) is a common cause of upper and lower respiratory tract illness in infants and young children. Live-attenuated cold-adapted HPIV3 vaccines have been evaluated in infants but a suitable interval for administration of a second dose of vaccine has not...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Englund, Janet A., Karron, Ruth A., Cunningham, Coleen K., LaRussa, Philip, Melvin, Ann, Yogev, Ram, Handelsman, Ed, Siberry, George K., Thumar, Bhavanji, Schappell, Elizabeth, Bull, Catherine V., Chu, Helen Y., Schaap-Nutt, Anne, Buchholz, Ursula, Collins, Peter L., Schmidt, Alexander C.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Ltd. Published by Elsevier Ltd. 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889708/
https://ncbi.nlm.nih.gov/pubmed/24103895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.09.046
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars